Neuropsychological deficits associated with antiphospholipid antibodies.

No abstract is available for this paper.

• Publication year

  1999

• Venue

  Journal of Clinical and Experimental Neuropsychology

• Publication date

  1999-04-01

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1076/JCEN.21.2.251.931PMID 10425522
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Role of anticardiolipin antibodies in young persons with migraine and transient focal neurologic events

  1998cited by this paper
• Patients with antiphospholipid antibodies: CT and MR findings of the brain.

  1996cited by this paper
• Cognitive and neurobiologic markers of early Alzheimer disease.

  1996cited by this paper
• Distinct cognitive profiles of cortical and subcortical dementia in advanced illness

  1995cited by this paper
• Anticardiolipin antibodies in normal subjects. Neuropsychological correlates and MRI findings.

  1995cited by this paper
• A young case with multi-infarct dementia associated with lupus anticoagulant.

  1994cited by this paper
• Verbal memory performance of patients with human immunodeficiency virus infection: evidence of subcortical dysfunction. The HNRC Group.

  1994cited by this paper
• Tourette's disorder: is there an association with the antiphospholipid syndrome?

  1994cited by this paper
• Neurobehavioral presentations of the antiphospholipid antibody syndrome.

  1993cited by this paper
• The antiphospholipid syndrome: ten years on.

  1993cited by this paper
• Autoimmunity in depression: increased antiphospholipid autoantibodies

  1993cited by this paper
• Higher cortical dysfunction, antiphospholipid antibodies and neuroradiological examinations in systemic lupus erythematosus.

  1992cited by this paper
• Lupus Anticoagulant and Anticardiolipin Antibodies in Young Adults With Cerebral Ischemia

  1992cited by this paper
• Antiphospholipid antibody syndrome.

  1992cited by this paper
• Visuospatial attention in dementia of the Alzheimer type.

  1992cited by this paper
• Antiphospholipid Thrombosis: Clinical Course after the First Thrombotic Event in 70 Patients

  1992cited by this paper
• Anticardiolipin antibodies, a disease marker for ischemic cerebrovascular events in a younger patient population?

  1992cited by this paper
• Elevated IGG and IGM anticardiolipin antibodies in a subgroup of medicated and unmedicated schizophrenic patients.

  1991cited by this paper
• Antiphospholipid antibodies in cerebral ischemia.

  1991cited by this paper
• Anticardiolipin antibodies

  1991cited by this paper
• Clinical and laboratory findings in patients with antiphospholipid antibodies and cerebral ischemia. The Antiphospholipid Antibodies in Stroke Study Group.

  1990cited by this paper
• Antiphospholipid antibodies: anticardiolipin and the lupus anticoagulant in systemic lupus erythematosus (SLE) and in non-SLE disorders. Prevalence and clinical significance.

  1990cited by this paper
• Antiphospholipid antibodies, prethrombotic states, and stroke.

  1990cited by this paper
• Cerebrovascular and neurologic disease associated with antiphospholipid antibodies

  1990cited by this paper
• Neurological disease associated with antiphospholipid antibodies

  1989cited by this paper
• Amaurosis fugax associated with antiphospholipid antibodies

  1989cited by this paper
• Familial occurrence of the antiphospholipid syndrome.

  1989cited by this paper
• Antiphospholipid antibodies--autoantibodies with a difference.

  1988cited by this paper
• Immune mediated mechanism for thrombosis: antiphospholipid antibody binding to platelet membranes.

  1988cited by this paper
• The spectrum of neurologic disease associated with antiphospholipid antibodies. Lupus anticoagulants and anticardiolipin antibodies.

  1987cited by this paper
• Recurrent stroke and multi-infarct dementia in systemic lupus erythematosus: association with antiphospholipid antibodies.

  1987cited by this paper
• Multiple cerebral infarctions and dementia associated with anticardiolipin antibodies.

  1987cited by this paper
• Circulating coagulation inhibitors in the acquired immunodeficiency syndrome.

  1986cited by this paper
• Anti-phospholipid antibodies.

  1985cited by this paper
• “Lupus” Anticoagulant and Thrombosis – Possible Role of Inhibition of Prostacyclin Formation

  1982cited by this paper

• The impact of antiphospholipid antibodies/antiphospholipid syndrome on systemic lupus erythematosus.

  2024cites this paper
• Neurovascular Issues in Antiphospholipid Syndrome: Arterial Vasculopathy from Small to Large Vessels in a Neuroradiological Perspective

  2024cites this paper
• Antiphospholipid syndrome mimicking posterior cortical atrophy and the "railroad track" sign on brain fluorodeoxyglucose-positron emission tomography.

  2023cites this paper
• The clinical features and potential mechanisms of cognitive disorders in peripheral autoimmune and inflammatory diseases

  2022cites this paper
• Cognitive Impairment in Anti-Phospholipid Syndrome and Anti-Phospholipid Antibody Carriers

  2022cites this paper
• Neurologic Manifestations of the Antiphospholipid Syndrome — an Update

  2021cites this paper
• Assessment of Cognitive Function in Systemic Lupus Erythematosus

  2021cites this paper
• Management of Non-criteria Manifestations in Antiphospholipid Syndrome

  2020cites this paper
• Cognitive dysfunction and serum levels of brain-derived neurotrophic factor (BDNF) in primary anti-phospholipid syndrome (PAPS).

  2020cites this paper
• The immunologic etiology of psychiatric manifestations in systemic lupus erythematosus: A narrative review on the role of the blood brain barrier, antibodies, cytokines and chemokines.

  2020cites this paper
• Differential diagnosis of multiple sclerosis and other inflammatory CNS diseases.

  2020cites this paper
• Relationship of Antiphospholipid Antibodies to Risk of Dementia: A Systematic Review

  2019cites this paper
• Antiphospholipid Antibody Syndrome Causing Progressive Central Nervous System Dysfunction in a Young Patient

  2019cites this paper
• Neuroscientific Research for Management of Dementia

  2019cites this paper
• Decreased hippocampal cell proliferation in mice with experimental antiphospholipid syndrome

  2018cites this paper
• Antiphospholipid Syndrome and the Neurologist: From Pathogenesis to Therapy

  2018cites this paper
• Manifestações critério e não critério na síndrome antifosfolípide

  2018cites this paper
• Presence of Anticardiolipin Antibodies in Patients with Dementia: A Systematic Review and Meta-Analysis

  2017cites this paper
• Central Nervous System Manifestations of Antiphospholipid Syndrome.

  2017cites this paper
• Neuropsychiatric Manifestations of Antiphospholipid Syndrome

  2017cites this paper
• Cognitive disorders and antiphospholipid antibodies.

  2016cites this paper
• Non-stroke Central Neurologic Manifestations in Antiphospholipid Syndrome

  2016cites this paper
• Functional Magnetic Resonance Imaging of Working Memory and Executive Dysfunction in Systemic Lupus Erythematosus and Antiphospholipid Antibody–Positive Patients

  2016cites this paper
• 'Non-Criteria' Neurologic Manifestations of Antiphospholipid Syndrome: A Hidden Kingdom to be Discovered.

  2016cites this paper
• Neuropsychiatric presentations of antiphospholipid antibodies.

  2015cites this paper
• Difficult Clinical Situations in the Antiphospholipid Syndrome

  2015cites this paper
• Antiphospholipid antibodies as biomarkers in psychiatry: review of psychiatric manifestations in antiphospholipid syndrome

  2015cites this paper
• Neurocognitive Function, Autoimmune Disorders and

  2014cites this paper
• Testing for Antiphospholipid Antibody ( aPL ) Specificities in Retrospective “ Normal ” Cerebral Spinal Fluid ( CSF )

  2014cites this paper
• Cognitive dysfunction in antiphospholipid antibody (aPL)-negative systemic lupus erythematosus (SLE) versus aPL-positive non-SLE patients.

  2014cites this paper
• Antiphospholipid Antibodies: Neuropsychiatric Presentations

  2013cites this paper
• Cognitive Disturbances in Sneddon and Antiphospholipid Syndromes

  2012cites this paper
• Cognitive Dysfunction and Antiphospholipid Antibodies

  2012cites this paper
• Autoantikörper und EEG-Befunde bei Patienten mit verschiedenen psychiatrischen Erkrankungen

  2011cites this paper
• Cognitive dysfunction and white matter abnormalities in antiphospholipid syndrome.

  2011cites this paper
• The antiphospholipid syndrome as a neurological disease.

  2010cites this paper
• Chapter 18 Difficult Clinical Situations in the Antiphospholipid Syndrome

  2009cites this paper
• NEUROLOGIC MANIFESTATIONS OF SYSTEMIC LUPUS ERYTHEMATOSUS AND ANTIPHOSPHOLIPID ANTIBODY SYNDROME

  2008cites this paper
• Neurologic manifestations of the antiphospholipid syndrome: Integrating molecular and clinical lessons

  2008cites this paper
• ESTUDIO DE LA FUNCIÓN INMUNITARIA EN PACIENTES ESQUIZOFRÉNICOS Y BIPOLARES TIPO I

  2007cites this paper
• Neurological manifestations of the antiphospholipid syndrome: risk assessments and evidence‐based medicine

  2007cites this paper
• Neurologic manifestations of the antiphospholipid syndrome

  2007cites this paper
• [Neurological manifestations of the antiphospholipid syndrome].

  2005cites this paper
• Manifestaciones neurológicas en el síndrome antifosfolipídico

  2005cites this paper
• Neuropsychiatric Involvement in Systemic Lupus Erythematosus

  2004cites this paper
• Testing for Antiphospholipid Antibody (aPL) Specificities in Retrospective “Normal” Cerebral Spinal Fluid (CSF)

  2004cites this paper
• Cognitive dysfunction and antiphospholipid antibodies in systemic lupus erythematosus

  2003cites this paper
• Neuropsychological Functioning and Its Relationship to Antiphospholipid Antibodies in Patients With Systemic Lupus Erythematosus

  2002cites this paper
• Neurologic manifestations of the antiphospholipid syndrome

  2001cites this paper
• Update on antiphospholipid antibodies

  2000cites this paper
• Differential diagnosis of central nervous system manifestations of the antiphospholipid antibody syndrome.

  2000cites this paper
• Title : The impact of antiphospholipid antibodies/antiphospholipid syndrome on SLE

  year unknowninfluential citation